Diagnosis and therapy are walking together on radiopeptides' avenue.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Microscale radiosynthesis, preclinical imaging and dosimetry study of [Nuclear medicine and biology · 2018
   Article
2. [Molecular imaging and biology · 2017
   Article
3. PET/CT with (18)F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?European journal of nuclear medicine and molecular imaging · 2016
   Article
4. Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT(GSHMe)₂ to Detect Gamma Glutamyl Transferase Over Expressing Tumors.PloS one · 2015
   Article
5. Development of ⁶⁸Ga-labelled DTPA galactosyl human serum albumin for liver function imaging.European journal of nuclear medicine and molecular imaging · 2013
   Article
6. Toward tailored medicine (and beyond): the phaeochromocytoma and paraganglioma model.European journal of nuclear medicine and molecular imaging · 2012
   Article
7. Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.European journal of nuclear medicine and molecular imaging · 2011
   Article
8. Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.EJNMMI research · 2011
   Article

Corrections and comments

• Commented on by
  Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.2011
• Comment on
  Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as